EGFR and cancer: Protopine has been found to impair the cancer cell invasion and metastatic potential of MDA-MB-231 breast cancer cells by reducing the expression of adhesion molecules such as epidermal growth factor receptor (EGFR), ICAM-1 and integrins [161].